FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034687480> ?p ?o ?g. }

• W2034687480 endingPage "4053" @default.
• W2034687480 startingPage "4043" @default.
• W2034687480 abstract "BACKGROUND: Aberrant DNA methylation is a hallmark of cancer, and DNA methyltransferase inhibitors have demonstrated clinical efficacy in hematologic malignancies. On the basis of preclinical studies indicating that hypomethylating agents can reverse platinum resistance in ovarian cancer cells, the authors conducted a phase 1 trial of low-dose decitabine combined with carboplatin in patients with recurrent, platinum-resistant ovarian cancer. METHODS: Decitabine was administered intravenously daily for 5 days, before carboplatin (area under the curve, 5) on Day 8 of a 28-day cycle. By using a standard 3 + 3 dose escalation, decitabine was tested at 2 dose levels: 10 mg/m2 (7 patients) or 20 mg/m2 (3 patients). Peripheral blood mononuclear cells (PBMCs) and plasma collected on Days 1 (pretreatment), 5, 8, and 15 were used to assess global (LINE-1 repetitive element) and gene-specific DNA methylation. RESULTS: Dose-limiting toxicity (DLT) at the 20-mg/m2 dose was grade 4 neutropenia (2 patients), and no DLTs were observed at 10 mg/m2. The most common toxicities were nausea, allergic reactions, neutropenia, fatigue, anorexia, vomiting, and abdominal pain, the majority being grades 1-2. One complete response was observed, and 3 additional patients had stable disease for ≥6 months. LINE-1 hypomethylation on Days 8 and 15 was detected in DNA from PBMCs. Of 5 ovarian cancer-associated methylated genes, HOXA11 and BRCA1 were demethylated in plasma on Days 8 and 15. CONCLUSIONS: Repetitive low-dose decitabine is tolerated when combined with carboplatin in ovarian cancer patients, and demonstrates biological (ie, DNA-hypomethylating) activity, justifying further testing for clinical efficacy. Cancer 2010. © 2010 American Cancer Society." @default.
• W2034687480 created "2016-06-24" @default.
• W2034687480 creator A5000603863 @default.
• W2034687480 creator A5013167180 @default.
• W2034687480 creator A5013680538 @default.
• W2034687480 creator A5041038506 @default.
• W2034687480 creator A5043490198 @default.
• W2034687480 creator A5061888144 @default.
• W2034687480 creator A5062424421 @default.
• W2034687480 creator A5063081757 @default.
• W2034687480 creator A5082530577 @default.
• W2034687480 creator A5084939652 @default.
• W2034687480 creator A5086981588 @default.
• W2034687480 date "2010-06-08" @default.
• W2034687480 modified "2023-09-27" @default.
• W2034687480 title "A phase 1 and pharmacodynamic study of decitabine in combination with carboplatin in patients with recurrent, platinum-resistant, epithelial ovarian cancer" @default.
• W2034687480 cites W1493975626 @default.
• W2034687480 cites W1516613270 @default.
• W2034687480 cites W169172393 @default.
• W2034687480 cites W1964644808 @default.
• W2034687480 cites W1967308102 @default.
• W2034687480 cites W1967329640 @default.
• W2034687480 cites W1983307705 @default.
• W2034687480 cites W2005027487 @default.
• W2034687480 cites W2005941717 @default.
• W2034687480 cites W2017394727 @default.
• W2034687480 cites W2019535129 @default.
• W2034687480 cites W2022240113 @default.
• W2034687480 cites W2026843427 @default.
• W2034687480 cites W2038033170 @default.
• W2034687480 cites W2041273685 @default.
• W2034687480 cites W2043244590 @default.
• W2034687480 cites W2051658829 @default.
• W2034687480 cites W2056473117 @default.
• W2034687480 cites W2058977958 @default.
• W2034687480 cites W2062069198 @default.
• W2034687480 cites W2070957637 @default.
• W2034687480 cites W2086695635 @default.
• W2034687480 cites W2088561077 @default.
• W2034687480 cites W2097587005 @default.
• W2034687480 cites W2103041478 @default.
• W2034687480 cites W2106341289 @default.
• W2034687480 cites W2108160031 @default.
• W2034687480 cites W2108281054 @default.
• W2034687480 cites W2115954319 @default.
• W2034687480 cites W2126273255 @default.
• W2034687480 cites W2131099997 @default.
• W2034687480 cites W2138784667 @default.
• W2034687480 cites W2139248078 @default.
• W2034687480 cites W2141410747 @default.
• W2034687480 cites W2143034846 @default.
• W2034687480 cites W2143995836 @default.
• W2034687480 cites W2148660548 @default.
• W2034687480 cites W2148680303 @default.
• W2034687480 cites W2160149822 @default.
• W2034687480 cites W2162698716 @default.
• W2034687480 cites W2313554316 @default.
• W2034687480 cites W253251876 @default.
• W2034687480 cites W2593544160 @default.
• W2034687480 cites W4234338065 @default.
• W2034687480 cites W4253997817 @default.
• W2034687480 cites W4376561984 @default.
• W2034687480 cites W4377200472 @default.
• W2034687480 doi "https://doi.org/10.1002/cncr.25204" @default.
• W2034687480 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2930033" @default.
• W2034687480 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20564122" @default.
• W2034687480 hasPublicationYear "2010" @default.
• W2034687480 type Work @default.
• W2034687480 sameAs 2034687480 @default.
• W2034687480 citedByCount "134" @default.
• W2034687480 countsByYear W20346874802012 @default.
• W2034687480 countsByYear W20346874802013 @default.
• W2034687480 countsByYear W20346874802014 @default.
• W2034687480 countsByYear W20346874802015 @default.
• W2034687480 countsByYear W20346874802016 @default.
• W2034687480 countsByYear W20346874802017 @default.
• W2034687480 countsByYear W20346874802018 @default.
• W2034687480 countsByYear W20346874802019 @default.
• W2034687480 countsByYear W20346874802020 @default.
• W2034687480 countsByYear W20346874802021 @default.
• W2034687480 countsByYear W20346874802022 @default.
• W2034687480 countsByYear W20346874802023 @default.
• W2034687480 crossrefType "journal-article" @default.
• W2034687480 hasAuthorship W2034687480A5000603863 @default.
• W2034687480 hasAuthorship W2034687480A5013167180 @default.
• W2034687480 hasAuthorship W2034687480A5013680538 @default.
• W2034687480 hasAuthorship W2034687480A5041038506 @default.
• W2034687480 hasAuthorship W2034687480A5043490198 @default.
• W2034687480 hasAuthorship W2034687480A5061888144 @default.
• W2034687480 hasAuthorship W2034687480A5062424421 @default.
• W2034687480 hasAuthorship W2034687480A5063081757 @default.
• W2034687480 hasAuthorship W2034687480A5082530577 @default.
• W2034687480 hasAuthorship W2034687480A5084939652 @default.
• W2034687480 hasAuthorship W2034687480A5086981588 @default.
• W2034687480 hasBestOaLocation W20346874801 @default.
• W2034687480 hasConcept C104317684 @default.
• W2034687480 hasConcept C111113717 @default.
• W2034687480 hasConcept C112705442 @default.

• next